BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32304186)

  • 1. Cortical hyperexcitability evolves with disease progression in ALS.
    Menon P; Higashihara M; van den Bos M; Geevasinga N; Kiernan MC; Vucic S
    Ann Clin Transl Neurol; 2020 May; 7(5):733-741. PubMed ID: 32304186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis.
    Menon P; Geevasinga N; van den Bos M; Yiannikas C; Kiernan MC; Vucic S
    Eur J Neurol; 2017 Jun; 24(6):816-824. PubMed ID: 28436181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis.
    Geevasinga N; Menon P; Nicholson GA; Ng K; Howells J; Kril JJ; Yiannikas C; Kiernan MC; Vucic S
    JAMA Neurol; 2015 Nov; 72(11):1268-74. PubMed ID: 26348842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study.
    Higashihara M; Pavey N; Menon P; van den Bos M; Shibuya K; Kuwabara S; Kiernan MC; Koinuma M; Vucic S
    Eur J Neurol; 2024 Jul; 31(7):e16281. PubMed ID: 38504632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical contributions to the flail leg syndrome: Pathophysiological insights.
    Menon P; Geevasinga N; Yiannikas C; Kiernan MC; Vucic S
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):389-96. PubMed ID: 26888565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis.
    Vucic S; Cheah BC; Kiernan MC
    Exp Neurol; 2009 Nov; 220(1):177-82. PubMed ID: 19716820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia.
    Vucic S; Cheah BC; Yiannikas C; Vincent A; Kiernan MC
    Brain; 2010 Sep; 133(9):2727-33. PubMed ID: 20736187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Cortical Hyperexcitability and Cognitive Impairment in Patients With Amyotrophic Lateral Sclerosis.
    Higashihara M; Pavey N; van den Bos M; Menon P; Kiernan MC; Vucic S
    Neurology; 2021 Apr; 96(16):e2090-e2097. PubMed ID: 33827958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS.
    Menon P; Kiernan MC; Vucic S
    Clin Neurophysiol; 2015 Apr; 126(4):803-9. PubMed ID: 25227219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis.
    Geevasinga N; Menon P; Yiannikas C; Kiernan MC; Vucic S
    Eur J Neurol; 2014 Dec; 21(12):1451-7. PubMed ID: 24698287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights.
    Vucic S; Ziemann U; Eisen A; Hallett M; Kiernan MC
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1161-70. PubMed ID: 23264687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS.
    Geevasinga N; Menon P; Ng K; Van Den Bos M; Byth K; Kiernan MC; Vucic S
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):580-588. PubMed ID: 27249331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of motor cortical dysfunction in amyotrophic lateral sclerosis.
    Shibuya K; Simon NG; Geevasinga N; Menon P; Howells J; Park SB; Huynh W; Noto YI; Vucic S; Kiernan MC
    Clin Neurophysiol; 2017 Jun; 128(6):1075-1082. PubMed ID: 28400096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical excitability distinguishes ALS from mimic disorders.
    Vucic S; Cheah BC; Yiannikas C; Kiernan MC
    Clin Neurophysiol; 2011 Sep; 122(9):1860-6. PubMed ID: 21382747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis.
    Zanette G; Tamburin S; Manganotti P; Refatti N; Forgione A; Rizzuto N
    Clin Neurophysiol; 2002 Nov; 113(11):1688-97. PubMed ID: 12417221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticomotoneuronal integrity and adaptation in spinal muscular atrophy.
    Farrar MA; Vucic S; Johnston HM; Kiernan MC
    Arch Neurol; 2012 Apr; 69(4):467-73. PubMed ID: 22491191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.
    Vucic S; Kiernan MC
    Brain; 2006 Sep; 129(Pt 9):2436-46. PubMed ID: 16835248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical hyperexcitability and the split-hand plus phenomenon: pathophysiological insights in ALS.
    Bae JS; Menon P; Mioshi E; Kiernan MC; Vucic S
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):250-6. PubMed ID: 24555863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical dysfunction underlies the development of the split-hand in amyotrophic lateral sclerosis.
    Menon P; Kiernan MC; Vucic S
    PLoS One; 2014; 9(1):e87124. PubMed ID: 24475241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
    Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
    Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.